Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis

J. Laco, K. Sieglová, H. Vošmiková, P. Dundr, K. Němejcová, J. Michálek, P. Čelakovský, V. Chrobok, R. Mottl, A. Mottlová, L. Tuček, R. Slezák, M. Chmelařová, I. Sirák, M. Vošmik, A. Ryška,

. 2015 ; 467 (4) : 405-15. [pub] 20150731

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010018
E-zdroje Online Plný text

NLK ProQuest Central od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2003-01-01 do Před 1 rokem

Odkazy

PubMed 26229021
DOI 10.1007/s00428-015-1812-x
Knihovny.cz E-zdroje

The aim of the study was to investigate prevalence of high-risk human papillomavirus (HR-HPV) infection in sinonasal carcinomas by immunohistochemistry, in situ hybridization, and polymerase chain reaction, detecting p16(INK4a) protein (p16) expression and presence of both HPV DNA and HPV E6/E7 messenger RNA (mRNA). The study comprised 47 males and 26 females, aged 23-83 years (median 62 years), mostly (67 %) with a squamous cell carcinoma (SCC). Of the tumors, 53 % arose in the nasal cavity, 42 % in the maxillary sinus, and 5 % in the ethmoid complex. The follow-up period ranged 1-241 months (median 19 months). HPV16, HPV18, or HPV35 were detected in 18/73 (25 %) tumors, 17 SCCs, and 1 small cell neuroendocrine carcinoma. There was a strong correlation between results of HPV detection methods and p16 expression (p < 0.005). HPV-positive SCCs occurred more frequently in smokers (p = 0.04) and were more frequently p16-positive (p < 0.0001) and nonkeratinizing (p = 0.02), the latter occurring more commonly in nasal cavity (p = 0.025). Median survival for HPV-positive SCC patients was 30 months, while for HPV-negative SCC patients was 14 months (p = 0.23). In summary, we confirm that HR-HPV is actively involved in the etiopathogenesis of a significant subset of sinonasal SCCs. p16 may be used as a reliable surrogate marker for determination of HPV status also in sinonasal SCCs. Although we observed a trend toward better overall survival in HPV-positive SCCs, the prognostic impact of HPV status in sinonasal carcinomas needs to be elucidated by further studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010018
003      
CZ-PrNML
005      
20160412095251.0
007      
ta
008      
160408s2015 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00428-015-1812-x $2 doi
024    7_
$a 10.1007/s00428-015-1812-x $2 doi
035    __
$a (PubMed)26229021
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Laco, Jan $u The Fingerland Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. lacoj@lfhk.cuni.cz.
245    14
$a The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis / $c J. Laco, K. Sieglová, H. Vošmiková, P. Dundr, K. Němejcová, J. Michálek, P. Čelakovský, V. Chrobok, R. Mottl, A. Mottlová, L. Tuček, R. Slezák, M. Chmelařová, I. Sirák, M. Vošmik, A. Ryška,
520    9_
$a The aim of the study was to investigate prevalence of high-risk human papillomavirus (HR-HPV) infection in sinonasal carcinomas by immunohistochemistry, in situ hybridization, and polymerase chain reaction, detecting p16(INK4a) protein (p16) expression and presence of both HPV DNA and HPV E6/E7 messenger RNA (mRNA). The study comprised 47 males and 26 females, aged 23-83 years (median 62 years), mostly (67 %) with a squamous cell carcinoma (SCC). Of the tumors, 53 % arose in the nasal cavity, 42 % in the maxillary sinus, and 5 % in the ethmoid complex. The follow-up period ranged 1-241 months (median 19 months). HPV16, HPV18, or HPV35 were detected in 18/73 (25 %) tumors, 17 SCCs, and 1 small cell neuroendocrine carcinoma. There was a strong correlation between results of HPV detection methods and p16 expression (p < 0.005). HPV-positive SCCs occurred more frequently in smokers (p = 0.04) and were more frequently p16-positive (p < 0.0001) and nonkeratinizing (p = 0.02), the latter occurring more commonly in nasal cavity (p = 0.025). Median survival for HPV-positive SCC patients was 30 months, while for HPV-negative SCC patients was 14 months (p = 0.23). In summary, we confirm that HR-HPV is actively involved in the etiopathogenesis of a significant subset of sinonasal SCCs. p16 may be used as a reliable surrogate marker for determination of HPV status also in sinonasal SCCs. Although we observed a trend toward better overall survival in HPV-positive SCCs, the prognostic impact of HPV status in sinonasal carcinomas needs to be elucidated by further studies.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a spinocelulární karcinom $x mortalita $x patologie $x virologie $7 D002294
650    _2
$a DNA virů $x analýza $7 D004279
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory hlavy a krku $x mortalita $x patologie $x virologie $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádorové proteiny $x analýza $7 D009363
650    _2
$a onkogenní proteiny virové $x genetika $7 D009856
650    _2
$a Papillomaviridae $x izolace a purifikace $7 D027383
650    _2
$a Papillomavirus E7 - proteiny $x genetika $7 D050725
650    _2
$a nádory vedlejších dutin nosních $x mortalita $x patologie $x virologie $7 D010255
650    _2
$a messenger RNA $x analýza $7 D012333
650    _2
$a represorové proteiny $x genetika $7 D012097
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a genetická transkripce $7 D014158
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sieglová, Kateřina $u The Fingerland Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
700    1_
$a Vošmiková, Hana $u The Fingerland Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
700    1_
$a Dundr, Pavel $u Department of Pathology, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Němejcová, Kristýna $u Department of Pathology, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Michálek, Jaroslav $u Department of Clinical and Molecular Pathology, Palacky University Olomouc, Faculty of Medicine and Dentistry and University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Čelakovský, Petr $u Department of Otorhinolaryngology and Head and Neck Surgery, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Chrobok, Viktor $u Department of Otorhinolaryngology and Head and Neck Surgery, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Mottl, Radovan $u Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Mottlová, Alena $u Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Tuček, Luboš $u Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Slezák, Radovan $u Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Chmelařová, Marcela $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Sirák, Igor $u Department of Oncology and Radiotherapy, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Vošmik, Milan $u Department of Oncology and Radiotherapy, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Ryška, Aleš $u The Fingerland Department of Pathology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
773    0_
$w MED00004660 $t Virchows Archiv an international journal of pathology $x 1432-2307 $g Roč. 467, č. 4 (2015), s. 405-15
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26229021 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160412095334 $b ABA008
999    __
$a ok $b bmc $g 1113447 $s 934386
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 467 $c 4 $d 405-15 $e 20150731 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace